Brazil vs Czechia: Proportion of bloodstream infection due to methicillin-resistant
Brazil
27.5%
in 2023
Czechia
28.5%
in 2023
Brazil rank
29th
Czechia rank
27th
Proportion of bloodstream infection due to methicillin-resistant over time
- Brazil
- Czechia
How they compare
Czechia currently reports 28.5% against 27.5% in Brazil, a difference of 1.0%.
The two have swapped places 4 times across 6 shared years of data; in 2018 it was Czechia ahead.
Brazil ranks 29th and Czechia ranks 27th of 55 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.8% | 13.1% | 2.8% | Brazil |
| 2020s | 22.6% | 13.7% | 8.9% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Brazil or Czechia?
- Czechia, at 28.5% against 27.5% in Brazil as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Brazil and Czechia?
- 1.0%, with Czechia ahead.
- How many years of comparable data are there for Brazil and Czechia?
- 6 years are reported by both, from 2018 to 2023.
- How do Brazil and Czechia rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Brazil ranks 29th and Czechia ranks 27th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.